Home
Conditions
Thymus Neoplasms

Clinical trial condition

Thymus Neoplasms

Explore clinical trials studying Thymus Neoplasms. Study availability and eligibility vary by location and protocol.

35 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Thymus Neoplasms trial results

Not yet recruiting

Hypofractionated Adjuvant Radiotherapy for Thymic Epithelial Tumors

NCT07693855

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +9 more
Locations: China Medical University Hospital Taichung, Taiwan

National Taiwan University Hospital Taipei, Taiwan

National Taiwan University Cancer Center Taipei, Taiwan

View Trial Details

Not yet recruiting

Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial

NCT06750952

Conditions: Disease Attributes, First-line Treatment, Hemic and Lymphatic Diseases, +9 more
Locations: Not specified

View Trial Details

Enrolling by invitation

Molecular Analysis of Thoracic Malignancies

NCT01385722

Conditions: Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +20 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Active, not recruiting

Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma

NCT04417660

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +10 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, not recruiting

Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection

NCT06189183

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +3 more
Locations: National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Active, not recruiting

Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

NCT04459273

Conditions: Adenocarcinoma, Adrenal Gland Diseases, Adrenal Gland Neoplasms, +77 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, not recruiting

A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers

NCT05544929

Conditions: Adenocarcinoma, Adenocarcinoma, Clear Cell, Adenoma, +83 more
Locations: Massachusetts General Hospital . Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

NYU School of Medicine New York, United States

University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

View all 19 locations

View Trial Details

Completed

Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies

NCT03447470

Conditions: Biliary Tract Diseases, Biliary Tract Neoplasms, Cancer, +9 more
Locations: Royal Marsden Hospital, Institute of Cancer Research Sutton, Surrey, United Kingdom

Guys Hospital London, United Kingdom

The Christie NHS Foundation Trust Manchester, United Kingdom

Sir Bobby Robson Cancer Trials Research Centre Newcastle, United Kingdom

View Trial Details

Completed

The Registry of Oncology Outcomes Associated With Testing and Treatment

NCT04028479

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more
Locations: Teton Cancer Institute Idaho Falls, Idaho, United States

Oncology and Hematology of South Texas Laredo, Texas, United States

View Trial Details

Completed

Sunitinib for Advanced Thymus Cancer Following Earlier Treatment

NCT01621568

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Neoplasms, +6 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Thymus Neoplasms

Thymus Neoplasms trial results

Related conditions